Skip to content

Comparison Between Combined Biceps Femoris Short Head Block and Adductor Canal Block Versus Genicular Nerve Block

Enhanced Analgesia in Elderly After Total Knee Arthroplasty Using Combined Biceps Femoris Short Head Block and Adductor Canal Block Versus Genicular Nerve Block

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07418307
Enrollment
50
Registered
2026-02-18
Start date
2026-02-15
Completion date
2026-11-15
Last updated
2026-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Arthroplasty, Total

Brief summary

The purpose of this study is to compare the analgesic outcomes (time to first analgesic request, total amount of analgesic consumption, and pain scores) following total knee arthroplasty by either combined biceps femoris short head block and adductor canal block or genicular nerve block in elderly patients.

Interventions

OTHERCombined biceps femoris short head block and adductor canal block

Adductor Canal Block high-frequency probe will be placed transversely on the anterior thigh midpoint between inguinal crease and medial condyle (depth 3-5 cm). The needle will be advanced in-plane from lateral to medial through sartorius or vastus medialis muscle toward the femoral artery. Then (10 ml of 0.25% bupivacaine and 2 mg dexamethasone) will be injected after negative aspiration, with confirming spread around the artery without vascular puncture. Biceps femoris short head block The probe will be placed on the distal posterior thigh to visualize biceps femoris muscle near the lateral supracondylar line of the femur. The needle will be inserted to the interface between biceps femoris and femur cortex. Then (25 ml of 0.25% bupivacaine and 2 mg dexamethasone), with observing muscle lift and circumferential spread along the bone surface .

Position the patient will be placed in supine position with the knee slightly flexed via a pillow in the popliteal fossa. Use a high-frequency linear ultrasound transducer. Superolateral genicular nerve (SLGN): the transducer will be placed coronally over lateral femoral epicondyle, with sliding proximally to femur metaphysis; identifying artery between vastus lateralis fascia and bone. Superomedial genicular nerve (SMGN): the transducer will be placed coronally over medial femoral epicondyle, proximal to adductor tubercle at femur metaphysis; artery between vastus medialis fascia and bone. Inferomedial genicular nerve (IMGN): the transducer will be placed coronally over medial tibial condyle, distal to metaphysis; artery beneath medial collateral ligament. • Inferolateral genicular nerve (ILGN, optional): the transducer will be placed coronally over lateral tibial epicondyle to fibula head; artery between collateral ligament and tibia

Sponsors

Zagazig University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patient acceptance * Physical status: ASA I, II and Ⅲ. * Body mass index (BMI): 18.5 - 35 kg/m2. * Type of operations: total knee arthroplasty.

Exclusion criteria

* Known hypersensitivity to dexamethasone or bupivacaine. * Coagulation disorders or taking drugs affect surgical hemostasis. * Patients with pre-existing neurological deficits. * Uncooperative patient or with altered mental status. * Patient with advanced cardiovascular or respiratory diseases or uncontrolled diabetes

Design outcomes

Primary

MeasureTime frameDescription
Time of first rescue analgesia (naluphine)24 hours postoperativeto the duration from the block to the moment when the patient first requires or requests supplemental nalbuphine due to breakthrough pain

Secondary

MeasureTime frameDescription
patient's satisfaction24 hours postoperativeThe patients will be asked to rate the overall degree of satisfaction of the analgesia by using a 5-points likert-like verbal scale (1 = very dissatisfied analgesia, 2 = dissatisfied analgesia, and 3 = neutral, 4=satisfied analgesia, and 5=very satisfied analgesia)
Block related complications24 hours postoperative(motor weakness, hematoma, local anesthetic toxicity,..)
Pain intensity30 minutesn2, 4, 8, 12, 18 , and 24 hours postoperative10-point NRS \[(0 = no pain, 10 = worst imaginable pain), 1-3: Mild pain (nagging, annoying, slightly interfering with activities of daily living (ADLs), 4 - 6: Moderate pain (significantly interfering with ADLs, 7 - 10: Severe pain (disabling, unable to perform ADLs)
Total amount of rescue analgesia (nalbuphine)first 24 hours postoperativethe cumulative dose of nalbuphine administered as supplemental pain relief during a defined postoperative observation period, typically when pain scores exceed a predefined threshold like NRS ≥4
assess functional recoveryat 12 hours and 24 hours postoperative(knee range of motion active flexion /extension,
block performance timetime of performance of the blocktime refers to the duration required to prepare, image (e.g., via ultrasound), insert the needle, and inject local anesthetic to complete a regional nerve block procedure.

Countries

Egypt

Contacts

CONTACTMarwa M Medhat, M.D
medhatmarwa9@gmail.com01002828937
CONTACTHowida A Kamal, M.D
K.Howida@yahoo.com01225096755
STUDY_DIRECTORHowida A Kamal, M.D

faculty of medicine,zagazig university Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026